Summit Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Summit Financial's LLY Position: Q2 2026 in Review
Summit Financial increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $3.24M and bringing the position to 31,495 shares worth $37.8M. The position accounts for 0.41% of the portfolio, ranked #38.
Summit Financial first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Summit Financial held 31,495 shares of Eli Lilly worth $37.8M as of Q2 2026.
- Summit Financial bought 3,172 Eli Lilly shares in Q2 2026, an estimated $3.24M.
- Eli Lilly made up 0.41% of Summit Financial's portfolio in Q2 2026, its #38 holding.
- Summit Financial first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.